PlainRecalls
FDA Devices Moderate Class II Terminated

Medtronic Cobalt HF CRT-D MRI SureScan DTPB2D1, MR Conditional implantable cardioverter defibrillator with cardiac resynchronization therapy, SureScan technology, and Bluetooth wireless telemetry (DDE-DDDR)

Reported: February 3, 2021 Initiated: November 15, 2020 #Z-0927-2021

Product Description

Medtronic Cobalt HF CRT-D MRI SureScan DTPB2D1, MR Conditional implantable cardioverter defibrillator with cardiac resynchronization therapy, SureScan technology, and Bluetooth wireless telemetry (DDE-DDDR)

Reason for Recall

Under rare circumstances, the component may be susceptible to a failure mechanism that could impact device performance, including potential loss of function.

Details

Units Affected
2 units
Distribution
Distribution to US states of GA, PA, NJ, and France
Location
Mounds View, MN

Frequently Asked Questions

What product was recalled?
Medtronic Cobalt HF CRT-D MRI SureScan DTPB2D1, MR Conditional implantable cardioverter defibrillator with cardiac resynchronization therapy, SureScan technology, and Bluetooth wireless telemetry (DDE-DDDR). Recalled by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF). Units affected: 2 units.
Why was this product recalled?
Under rare circumstances, the component may be susceptible to a failure mechanism that could impact device performance, including potential loss of function.
Which agency issued this recall?
This recall was issued by the FDA Devices on February 3, 2021. Severity: Moderate. Recall number: Z-0927-2021.